Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SHIRE LLC v. AMERIGEN PHARMACEUTICALS LIMITED
Case Number:
1:14-cv-06095
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 24, 2017
Adderall Generic Blocked After Shire, Amerigen Settle
A New Jersey federal judge on Monday permanently blocked Amerigen Pharmaceuticals Inc. from moving forward with a generic version of Shire LLC's attention deficit hyperactivity disorder medication Adderall XR before the patents expire, pursuant to a settlement between the drugmakers.
-
July 27, 2015
Shire Allowed Access To Confidential Info In Adderall Row
Amerigen Pharmaceuticals Inc. has to let Shire LLC look through its confidential information, namely its abbreviated new drug application, to figure out if it infringed Shire's patent for Adderall XR, a New Jersey magistrate judge ruled Friday.